Mr. Pierre Fitzgibbon reports

DR. TINA SAMPALIS APPOINTED MEDICAL SCIENCE LIAISON FOR NEPTUNE

Neptune Technologies & Bioressources Inc. and Acasti Pharma Inc.'s Dr. Tina Sampalis has transitioned from chief global strategic officer to a consulting role as medical science liaison for Neptune, starting immediately.

"On behalf of the board and management team of Neptune and Acasti, I would like to thank Tina for her leadership and service over the years," said Pierre Fitzgibbon, chairman of Neptune's board of directors and Acasti board member. "Tina made an important contribution to our success and we look forward to her continued guidance in her new role."

We seek Safe Harbor.